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ABSTRACT
Both obesity and pain are pervasive public health problems, contributing to significant
disability in the United States and worldwide. Studies have demonstrated a positive
association between obesity and pain, with increasing BMI related to increasing levels of pain
intensity; however, the mechanisms underlying this relationship are not well understood. The
present study assessed the presence of pain, pain-related disability, and pain beliefs in a
morbidly obese (BMI > 40 kg/m2) sample participating in a medically-supervised, nonsurgical
weight loss intervention. After controlling for demographic variables and depression, pain
was reported in 36.7% of the sample (N = 390). Results indicated that greater level of pain
severity at the outset of treatment was significantly associated with poorer weight loss
treatment outcome at one year [F(3, 205) = 20.50, p < .001]. Pain beliefs, specifically
catastrophizing, did not contribute to this relationship. The presence of pain was also
significantly related with decrements in health-related quality of life, after controlling for the
impact of age, BMI, and depression [F(4, 204) = 14.61, p < .001]. The findings of the present
study provide preliminary evidence that pain severity is an important indicator of treatment
outcomes for morbidly obese individuals trying to lose weight by nonsurgical methods.
Further research is needed to more clearly understand prognostic implications of the
comorbidity of pain on obesity treatment, as well as the impact of incremental weight loss on
pain outcomes.
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INTRODUCTION
The Obesity Epidemic
Obesity is a pervasive and costly public health phenomenon, heralded frequently as a
worldwide epidemic. Globally, the number of overweight and obese people is increasing
dramatically (Haslam and James, 2005). In the United States, the prevalence of obesity has risen
in every state over the last 15 years (Centers for Disease Control and Prevention, 2010; Flegal,
Carroll, Ogden, & Curtin, 2010). The simple definition of obesity as excess body fat is easy to
comprehend, but obesity is not as easy to measure due to the wide variability in human body
composition and shape. The World Health Organization (WHO) has adopted a definition for
overweight and obesity using the body mass index (BMI = weight/height2 in kg/m2). Obesity is
defined as a BMI greater than 30 kg/m2 (WHO, 2011). Recent data from the National Health and
Nutrition Examination Survey (NHANES) estimates that 68.3% of American adults were
classified as overweight (BMI > 25 kg/m2), and 33.9% were obese (Flegal, et al., 2010). Extreme
or morbid obesity, defined as BMI > 40 kg/m2, is remarkably prevalent in the United States,
occurring in 4.2% of men and 7.2% of women though 2008 (Flegal, et al., 2010), rising from
2.8% and 6.9%, respectively, in 2004 (Ogden, Carroll, Curtin, McDowell, Tabak, Flegal, 2006).
Over the last 20 years, more than 300 million people were classified as obese worldwide, and the
incidence of morbid obesity has doubled (Deitel, 2003).
The health burden associated with obesity is significant, as it contributes to the
development of numerous chronic medical illnesses (Bray, 2004). Obesity is associated with
coronary artery disease, hypertension, diabetes, congestive heart failure, sleep apnea,
hyperlipidemia, stroke, gallbladder disease, and a variety of cancers (Bray, 2004; Crawford,
Cote, Couto, Daskiran, Gunnarsson, Haas, et al., 2010). Furthermore, gastroesophageal reflux
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disease, nonalcoholic fatty liver disease, osteoarthritis, and psychological disturbances have
increased prevalence in obese patients and contribute to overall morbidity (Bray, 2004;
Crawford, et al., 2010). Obesity takes a great toll on American health and mortality, and it
remains the second leading preventable cause of mortality with an estimated 400,000 deaths
occurring annually (Mokdad, Marks, Stroup, & Gerberding, 2004).
Definitions of Obesity
The most elementary definition of obesity is excess adipose tissue in the body; however,
the pathophysiology of obesity is more complicated. Obesity is a problem of metabolic
dysfunction, affecting all major systems of the human body (Redinger, 2007). Weight gain and
obesity are described in the literature as the result of many factors, each individually complex:
genetic, physical, behavioral, and psychological. Defining the obesity epidemic as solely a
problem of imbalance of energy consumption (intake) to energy expenditure (activity) fails to
recognize the organ system and immune dysfunction that are both consequences of and
exacerbated by excessive body weight. Even further, immune dysfunction related to obesity has
created toxic metabolic environments that are not able to ward off further disease, instead
making the body readied for future illness. The multitude of comorbid conditions listed above is
evidence of this multi-organ dysfunction. Although varying from study to study, approximately
30 to 40% of the variance in BMI can be attributed to genetics and 60 to 70% to environment
(Pi-Sunyer, 2002). A widely-referenced analogy for this complexity is from Dr. George Bray,
“genes load the gun and a permissive or toxic environment pulls the trigger” (Bray, 2007, pg.
32). Indeed, the rapidity at which this epidemic is expanding worldwide indicates the strong
interaction of environment with the underlying susceptibility of the population.
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Bray described two pathophysiological categories for diseases related to obesity: the
increase in the number of fat cells or the increase in their size (Bray, 2004). Increased fat mass in
the body is affected by a number of factors, although androgen and estrogen hormones have the
greatest effect in early life and adolescence. Later age-related accumulation of fat is more likely
related to gender and associated changing levels of cortisol and testosterone. The increase in fat
mass affects the human body’s degree of insulin resistance, which can enhance the risk of
diabetes, gall bladder disease, hypertension, and cardiovascular disease. Increased fat mass is
also associated with osteoarthritis and sleep apnea, as well as social stigma, which can lead to
changes in behavioral responses (Bray, 2004). Individual fat cell enlargement is also important in
understanding overweight. The fat cell is a type of endocrine cell that directly creates metabolic
change through the release of peptides (Bray, 2004). Perhaps the most significant of these is
leptin, an adipose-released hormone that regulates the inhibition of appetite through the
hypothalamus (Caro & Considine, 2004). In simplistic terms, leptin is the body’s indicator of
energy balance. Although the precise dynamics of leptin are still being studied, it is understood
as having a direct influence on the body’s metabolism.
Treatment of Obesity
Obesity as a complex biological, environmental, psychological, and social phenomenon
similarly requires the implementation of multiple strategies in treatment. In recent decades, the
treatment for obesity has taken many forms, studied as individual components and taken together
in multiplicity: reduced energy consumption, increased energy expenditure, cognitive-behavioral
therapy, medications aimed at reducing adipose tissue or reducing the body’s ability to absorb
fats, and surgery to alter the body’s digestive processes. The application of one or more of these
strategies in a clinical setting is highly dependent on the obese individual. Wadden and

3

colleagues (2002, 2012) have suggested a treatment selection algorithm based on BMI
classification to help guide choice of treatment components.
According to the “BEST Treatment” assessment developed by Wadden and Phelan
(2003), the most effective non-surgical weight management interventions use a combined
approach of diet, physical activity, and behavior modification (Wadden, Webb, Moran, Bailer,
2012). Intensive medical approaches combining various elements of group behavior therapy,
individual behavior therapy, structured diet, very low calorie diets, physical activity regimens
and medications have been shown in small studies to produce weight loss that approximates 16%
or more from baseline (Pi-Sunyer, et al., 2007; Wadden, Berkowitz, Sarwer, Prus-Wisniewski,
Steinberg, 2001; Wadden, et al., 2012). Treatment studies have demonstrated that body weight
can be reduced in 6 months, although natural processes of maintenance are hard to achieve as
study samples repeatedly show regain after the 6 month mark (Wadden, et al., 2012). The more
successful treatments have aimed at what is termed “lifestyle modification,” in that participants
are educated on skills that are expected to continue well after the study period is over, with the
hopes that continued weight loss and management will continue over time (Wadden, Butryn,
Wilson, 2007). Lifestyle modification is the closest approximation of treatment that can broaden
not only to a way of eating and energy balance, but also healthy behaviors that aim to target
some of the comorbidities of obesity and overweight (Wadden, Butryn, Wilson, 2007; Wadden,
et al., 2012).
Standards for defining treatment success tend to differ by modality and BMI status. The
United States Institute of Medicine (IOM) published the long-held definition of a clinically
significant weight loss among nonsurgical treatment types as 10% loss of initial body weight
maintained for one year (IOM, 1995). This definition has been maintained by prominent obesity
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researchers in defining treatment success (Ryan, Johnson, Myers, Prather, McGlone, Rood, et al.,
2011; Wing & Hill, 2001; Wing & Phelan, 2005). This level of weight loss is associated with
improvement in related co-morbidities, such as hypertension, dyslipidemia, and insulin
insensitivity (National Institutes of Health and the National Heart, Lung, and Blood Institute,
2000). The United States Food and Drug Administration (USFDA) considers pharmacotherapy
as effective if treated patients lose 5% initial body weight (United States Department of Health
and Hospitals, 2007). However, these guidelines are not often applied in extreme obesity (BMI >
40 kg/m2), as nonoperative treatment strategies have not been demonstrated as effective in U.S.
samples (Wadden & Osei, 2003).
Treatment of Morbid Obesity. Extreme or morbid obesity is typically associated with
more serious health complications than lesser degrees of excess weight, and its treatment is
similarly more complex. Surgery is currently the only form of treatment for morbid obesity that
has been demonstrated to produce durable (i.e., 10 years’ duration) weight loss exceeding sixteen
percent of baseline weight (Martins, Strømmen, Stayne, Nossum, Mårvik, Kulsend, 2011;
Sjöström, 2000). Surgical therapy for obesity includes several different types of operations,
including more recently developed laparoscopic procedures to reduce postoperative infections
and complications (Tessier & Eagon, 2008). Although the NHLBI states doubt regarding the
effectiveness of “more conservative” (i.e., non-operative) procedures for extreme obesity in their
obesity treatment guidelines (2000), operative treatment is not possible for a large majority of
morbidly obese individuals. Many comorbidities of obesity, conditions which may be improved
with surgical treatment, may be severe enough health complications that actually preclude
surgical candidacy. Furthermore, bariatric procedures are costly, creating a financial burden as a
major medical procedure requiring extensive recovery and follow-up. Bariatric surgical
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procedures of all types can also create lifelong metabolic abnormalities, with both psychological
and social implications. Given that the number of surgical procedures performed in the U.S.
represents only a small fraction of the population with extreme obesity (Zhao & Encinosa, 2007),
continued research of non-operative methods of treatment for this group are necessary.
Pain as a Comorbidity
Despite a large body of research examining the multitude of obesity comorbidities, one
concomitant problem that is often overlooked is pain. Like obesity, pain is a complex
phenomenon, with biological, psychological, and social factors affecting an individual’s
development and experience of pain. The International Association for the Study of Pain (IASP,
2011, p. 25) published a widely accepted definition of pain as, “An unpleasant sensory and
emotional experience associated with actual or potential tissue damage, or described in terms of
such damage … Pain is always subjective … It is unquestionably a sensation in a part or parts of
the body, but it is also always unpleasant and therefore also an emotional experience.” This
definition highlights pain as a sensory process, acknowledging the action of the body’s sensory
organs and receptors to convert physical stimuli and energy into neural impulses sent to the
brain. However, the IASP emphasizes pain as a subjective experience and perceptive process,
highlighting the importance of the brain’s organization and interpretation of these neural
impulses. Pain is an individual experience with severity defined across a broad continuum
(IASP, 1994; IASP, 2011). Pain sensation, transmission, modulation, and interpretation are
functions of the central nervous system, and when abnormalities in these processes occur, pain is
regarded as a neurologic disease (Board on Health Sciences Policy, 2011).
Assessment of Pain. Given the IASP definition of pain as a subjective experience, the
assessment of pain is inherently different than that of weight. While excess fat mass is a
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quantifiable condition that can be seen, weighed, and measured without the input of the
individual, an outsider cannot detect an individual’s pain through their own senses. Although
clinical findings (i.e., broken bone or tissue damage) or pain-related behaviors (i.e., grimacing or
changes in mobility) may be observed, these do not correlate well with the severity of pain
reported by patients (Melzak & Katz, 1994; Miaskowski, Bair, Chou, D’Arcy, Hartwick,
Huffman, et al., 2008). Because pain often occurs in the absence of observable injury, the longstanding gold standard for pain assessment has been self-report (Cleeland, 1989; Greve,
Bianchini, Ord, 2012; Melzak & Katz, 1994). However, assessment by this method must be
cautious given that self-reporting can be influenced by numerous factors including cognitive
abilities, mood, sleep disturbance, and medication usage (Peter & Watt-Watson, 2002).
Secondarily, pain may be measured by the observance of a number of pain-related behaviors,
including the monitoring of medication usage (Greve, Bianchini, Ord, 2012; Melzak & Katz,
1994).
The importance of pain assessment is underscored by its economic impact. Like obesity,
pain is a pervasive and expensive public health problem, with chronic pain affecting an estimated
116 million American adults (Board on Health Sciences Policy, 2011). Arthritic pain is the
leading cause of disability in the United States (National Center for Chronic Disease Prevention
and Health Promotion, 2011). Pain represents an estimated $635 billion in costs from medical
treatment and lost productivity (Board on Health Sciences Policy, 2011), as well as reduced job
performance (Stewart, Ricci, Chee, Morganstein, Lipton, 2003). The lack of attention to pain in
obese populations is perhaps not surprising given that underassessment of pain is extremely
common, even despite its being the number one reason people seek medical attention (Berry &
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Dahl, 2000). In fact, the most common reason for the undertreatment of pain is the failure of
clinicians to assess pain and pain relief (Miaskowski, et al., 2008).
Co-occurrence of Obesity and Pain. Increasing levels of pain have been observed
across the continuum of BMI classification, from healthy BMI to extreme obesity (Stone &
Broderick, 2012). Results from a community-based twin registry confirmed the relationship
between weight and a variety of painful conditions (e.g., low back pain, headache, fibromyalgia,
chronic widespread pain; Wright, Schur, Noonan, Ahumada, Buchwald, Afari, 2010).
Specifically, overweight and obese twins were more likely to report these conditions than normal
weight twins after controlling for age, gender, and depression (Wright, et al., 2010). In a survey
sample of over 3,500 individuals living in the southeast U.S., Hitt and colleagues (2007) reported
that BMI was positively associated with increased pain over the last month. Importantly, this
association was observed across the spectrum of BMI classification, even after controlling for
age, gender, race, education, and the presence of healthcare coverage (Hitt, McMillan, ThorntonNeaves, Koch, Cosby, 2007). Furthermore, individuals classified with extreme obesity (BMI >
40 kg/m2) were 2.3 times more likely than those with lesser degrees of obesity to report moderate
to severe pain (Hitt,et al., 2007). The most recent survey of obesity and pain in a sample of over
one million U.S. adults, conducted by The Gallup Organization, found that BMI and pain
yesterday were reliably associated when demographic variables were controlled. This association
was found in both men and women, and became stronger in older adults (Stone & Broderick,
2012). Similarly, results from 407 participants in the Einstein Aging Study demonstrated that
central (i.e., abdominal) obesity had the strongest independent association with pain over the last
three months (Ray, Lipton, Zimmerman, Katz, Derby, 2011). Ray and colleagues noted that the
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relationship between obesity and pain in older adults was independent, not explained by
coexisting markers of insulin resistance or inflammation, osteoarthritis, or neuropathy.
Of the studies that assess for the presence of pain in obese populations, compelling
numbers have emerged. Fontaine and Barofsky (2001) found that of the 312 overweight
participants seeking weight management in their university setting, over half (56%) of the
participants reported moderate or severe pain. The most common types of pain were low back
pain and joint pain. In another study, Fontaine and colleagues also observed that 56% of their
“treatment-seeking” sample of obese persons had co-existing chronic pain, with low back pain
being the most prevalent pain condition in this group (Fontaine, Bartlett, Barofsky, 2000). When
compared to their non-treatment-seeking but similarly obese counterparts, pain was still observed
in nearly one-third of participants (Fontaine, et al, 2000). In one of the largest samples to date,
the Swedish Obese Subjects (SOS) study documented that of their 6,238 obese registry subjects,
the percentage reporting pain in at least one of five locations was 57.9% for men and 68% in
women (Peltonen, Lindroos, Torgeson, 2003).
Pain Conditions Associated with Obesity. Although an analysis of all possible pain
conditions is outside of the scope of the present dissertation, there are a number of conditions
that have been examined as related to increased weight: osteoarthritis, low back pain, and
chronic widespread pain (Janke, Collins, Kozak, 2007), as well as fibromyalgia (Okifugi,
Donaldson, Barck, Fine, 2010). Perhaps the most logical association of pain resulting from
overweight and obesity is musculoskeletal pain, as it may be intuitive that increasing pressure
placed on the body’s joints, muscles, and connective tissue by excess weight would cause pain.
Reciprocally, reduced activity resulting from premorbid musculoskeletal disorder could lead to
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weight gain. Two musculoskeletal conditions, osteoarthritis and low back pain, are the most
frequently examined in relation to obesity (Janke, et al., 2007).
Osteoarthritis is the most common joint disorder, characterized by pain and stiffness in
the joints, inflammation, tenderness, and limitation of joint movement (Tietel & Zieve, 2011).
Although the course of osteoarthritis varies, it is often both progressive and irreversible.
Treatment can range from use of over-the-counter medications such as Tylenol or non-steroidal
anti-inflammatory drugs to the injection of corticosteroids or artificial joint fluid (Tietel & Zieve,
2011), as well as surgical joint replacement (Janke, et al., 2007). Osteoarthritis of the knee and
hip tend to be the most disabling sites, contributing to excess health care utilization independent
of demographic variables and comorbidities including obesity (Wright, Katz, Cisternas, Kessler,
Wagenseller, Losina, 2010). Research evidence demonstrates that high BMI is a risk factor for
the development and progression of osetoarthritis in these areas. Analyses from the earliest
NHANES data showed that adults with BMI > 30 kg/m2 had a four times greater prevalence of
osteoarthritis of the knee than individuals with BMI < 30 kg/m2 (Anderson & Felson, 1988).
Later research not only concurs with these results (Felson, 1990), but indicates further increasing
prevalence of osteoarthritis of the knee and hip in the context of the obesity epidemic (Wang &
Beydoun, 2007; Losina, Walensky, Reichman, et al., 2011). The American College of
Rheumatology treatment guidelines recommend weight loss for overweight and obese
individuals with osteoarthritis (American College of Rheumatology Subcommittee on
Osteoarthritis, 2000). Among normal weight individuals, moderate increases in BMI have been
demonstrated as significantly related to knee osteoarthritis, indicating that even modest levels of
overweight may increase the risk for developing the disorder (Holmberg, Thelin, & Thelin,
2005).

10

Low back pain is also a chronic pain condition, and a common health problem of many
adults (Brooks, 2006). Yet, definitions of low back pain lack uniformity (Hoy, March, Brooks, et
al., 2010), and research regarding the nature of the relationship between low back pain and
obesity lacks conclusive evidence (Janke, et al., 2007; Sellinger, Clark, Shulman, Rosenberger,
Heapy, Kerns, 2010). Several studies have identified increased body weight as an independent
risk factor for the development of chronic back pain in both women and men (Brown, Mishra,
Kenardy, et al., 2000; Fransen, Woodward, Norton, et al., 2002; Lake, Power, Cole, 2000;
Sellinger, et al., 2010; Shiri, Karppinen, Leino-Arjas, Solovena, Viikara-Juntura, 2010; Webb,
Brammah, Lunt, Urwin, Allison, Symmons, 2003), suggesting a possible dose-response
relationship. Similarly, a large cross-sectional study of over 15,000 participants with common
spine disorders and related pain found that increased BMI was positively associated with
increased disability and severity of pain symptoms (Fanuele, Abdu, Hanscom, Weinstein, 2002),
but also with more comorbidities when compared to a nonobese sample. Longitudinal studies,
however, do not show a causal relationship between overweight & obesity and low back pain
(Janke, et al., 2007; Shiri et al., 2010). In their review, Janke and colleagues (2007) suggested
that the difficulty in understanding the relationship can be explained by poorly definitions of low
back pain, mediation by lifestyle factors, and an overall weak relationship that is likely stronger
in much higher BMI (> 30 kg/m2) classifications, rather than across the spectrum. More recently,
neuroengineering studies have made attempts to explain the obesity-low back pain relationship,
demonstrating that significant gait disturbance (Cimolin, Vismara, Galli, Zaina, Negrini,
Campodaglio, 2011) and spinal mobility impairment (Vismara, Menegoni, Zaina, Galli, Negrinir,
Capodaglio, 2010) are found in obese adults with low back pain, when compared to obese
individuals without low back pain.
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Physical Disability and Quality of Life. The comorbidity of physical pain and obesity
may act in a reciprocal fashion to increase physical disability. For example, the presence of pain
may contribute to weight gain and/or impaired weight maintenance through increased disability
and inactivity. Marcus (2004) observed that amongst a sample of chronic pain patients, 63%
were found to be overweight or obese. In this sample, the “impact” of pain (as measured by
reduced physical functioning and increased frequency of disability) was greater in patients with
increased BMI, with the greatest impact noted in obese patients (Marcus, 2004). Alternatively,
overweight may increase the risk for pain-related illness as described above through increased
load on the joints, lower back, or lower limbs. Coggon and colleagues (2001) attributed 24% of
required surgical corrections of osteoarthritis to obesity. Other researchers have postulated that it
is the sedentary lifestyle of overweight individuals that may contribute to increased risk of low
back pain (Leboeuf-Yde, Kyvik, Bruun, 1999; Shiri, et al., 2010).
While obesity studies typically have not focused on the overt assessment or functional
impact of pain in their samples, pain has emerged as important covariate within quality of life
data. Several studies incorporating the use of the Medical Outcomes Survey have unanimously
found that even mildly elevated BMI is associated with increased bodily pain, and increased
BMI and the presence of pain predict impaired quality of life on the physical domains of the
survey (Doll, Petersen, & Stewart-Brown, 2000; Fine, Colditz, Coakley, et al., 1999; Yancy,
Olsen, Westman, Bostworth, & Edelman, 2002). However, pain itself may take a unique toll on
quality of life in obese persons. Fontaine, Barofsky and colleagues (1997, 2001) were the first to
suggest that pain contributed independently to decrements in health-related quality of life
(HRQL). They found when compared to obese persons not reporting pain, obese persons
reporting pain were more significantly impaired on all domains of the Medical Outcomes Survey
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(SF-36), with the strongest effects appearing on the physical components scale. Moreover, these
differences held even after controlling for sociodemographic factors, BMI, and depression. In
support of these findings, Heo et al. (2003) conducted an analysis of the 1999 Behavioral Risk
Factor Surveillance Survey. They concluded that the relationship between high BMI and
decreased HRQL was very strongly mediated by joint pain. These two findings suggest that the
unique and independent contribution of pain to HRQL in obese persons is an important question
to explore.
Mechanisms of the Obesity-Pain Relationship. Although many studies demonstrate a
positive association between weight status and pain, investigation of the underlying relationship
is lacking. Mechanisms hypothesized for this link include mechanical-structural, metabolic, and
behavioral (Janke, et al., 2007; Stone & Broderick, 2012). Given the complex pathophysiology
of obesity and pain individually, it is likely that a combination of these factors is responsible for
the relationship between the conditions. Mechanical and structural links have been suggested
above, with the most discernible of those being excess weight creating excess load onto the
body’s joints. Chronic pressure on the joints may have further adverse effects on bones,
connective tissue, and muscle (Fabris de Souza, Faintuch, Valezi, et al., 2005). Other
hypothesized mechanical-structural links include gait disturbance (Cimolin et al., 2011), limited
range of spinal movement (Vismara, et al., 2010), and decreased ambulation and conditioning
(Ray, et al., 2011; Yamakawa, Tsai, Haig, Miner, Harris, 2004). Physiologic processes involving
insulin resistance and inflammation are also hypothesized. Obese individuals have an increased
risk for various metabolic disorders, indicating that they may have an increased vulnerability to
diabetes-related neuropathic pain (Janke, et al., 2007). Sandell (2009) implicates leptin, a proinflammatory hormone released by adipose tissue, which is independently associated with insulin
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resistance and cardiovascular disease. This hypothesis suggests that having excess fat leads to the
pathophysiologic processes of inflammation and related pain (Bray & Bellanger, 2006).
Behavioral hypotheses suggest that lifestyle and psychosocial factors (e.g., diet, activity level,
overall health status, smoking) may indicate shared pathways to both obesity and pain. Pain is
also a likely risk factor for weight gain, resulting from reduced activity levels and muscle
deconditioning (Janke, et al., 2007).
Pain Beliefs. Considering the IASP definition of pain as a subjective experience, and the
reliance on self-report measures in the assessment of pain, it is important to understand the role
of cognitive factors in the individual’s experience of pain. Pain beliefs are thoughts that
influence one’s physical, psychological, and behavioral reactions to pain. Catastrophizing is a
pain belief that is reported to correlate with self-report measures of pain intensity (Sullivan,
Thorn, Haythornthwaite, Keefe, Martin, Bradley, Lefebvre, 2001). It is the tendency of those in
pain to have an exaggerated and negative response to pain experiences and pain stimuli
(Sullivan, Bishop, & Pivik, 1995; Sullivan, et al., 2001), and the term “catastrophizing” was first
used by Albert Ellis, the founder of rational-emotional therapy (Ellis, 1962). Catastrophizing is
considered an important antecedent of pain intensity, and has been identified as a marker for
particularly poor response to medical treatments (Sullivan et al., 2001; Turner & Aaron, 2001).
However, to date, no published study has explored how the presence of catastrophizing may
affect individuals’ responsiveness to weight loss interventions.
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SUMMARY AND RATIONALE
The purpose of the present proposal was to assess the presence of pain, pain-related
disability, and pain beliefs in a morbidly obese sample participating in a medically-supervised,
nonsurgical weight loss intervention. It is important to research this comorbidity for several
reasons. Several studies have demonstrated a positive association between obesity and pain, with
increasing BMI related to increasing levels of pain intensity. Although this relationship is
observed across the continuum of BMI classification (Stone & Broderick, 2012), individuals
classified with extreme obesity are significantly more likely to report moderate to severe pain
(Hitt,et al., 2007). Given the commonality of pain in obese populations, particularly those that
are seeking weight management (Fontaine, Bartlett, Barofsky, 2000; Heo, Pietrobelli, Wang,
Heymsfield, Faith, 2010), it is suggested that greater attention to comorbid pain conditions is
warranted.
While available evidence suggests a likely relationship between obesity and pain, there is
much to learn about the nature of the association. The comorbidity of physical pain and obesity
may act in a reciprocal fashion to increase physical disability. Individuals with extreme obesity,
regardless of comorbid diagnoses, have a high level of physical disability (Marcus, 2004). In the
present study, it is presumed that the presence of self-reported pain will be related to a greater
“impact” on disability, as measured by reduced physical functioning and increased frequency of
disability, when compared to extremely obese individuals not reporting pain. This relationship is
especially important to understand for participants seeking weight loss treatment, as there is a
paucity of research directed toward understanding how pain may increase disability in this
unique sample (Heo, et al., 2010). Conversely, the ways in which medical interventions for
obesity do or do not assist in the management and impact of pain also remain unknown.

15

Although treatment guidelines for pain conditions (i.e., osteoarthritis) recommend weight loss,
there is much to understand about the impact on pain over the course of weight loss intervention.
Comorbidity of bodily pain and obesity may have important prognostic implications for
obesity treatment, and may directly mediate the effect of weight loss interventions. The presence
of pain may contribute unique treatment challenges in both surgical and non-surgical patients.
Dixon and colleagues (2001a) demonstrated that in bariatric surgery patients, the presence of
preoperative pain predicted less weight loss at one year. In another surgical study, preoperative
pain also predicted greater improvement in quality of life indicators post-surgery (Dixon, Dixon,
O’Brien, 2001b). Although it appears that those with pain may have the most to gain from
surgery, it may be difficult for many to achieve this goal with coexisting pain. Given that the
number of surgical procedures performed in the U.S. represents only a small fraction of the
population with extreme obesity (Zhao & Encinosa, 2007), continued research of non-operative
treatment for this group is necessary.
With respect to non-surgical interventions, pain appears to present a significant treatment
obstacle. Evidence from studies conducted with older adults with osteoarthritis has shown strong
support for the position that knee pain is an independent mediator for the effectiveness of
physical interventions (Rejeski, Ettinger, Martin, Morgan, 1998) and also of diet and exercise
interventions (Rejeski, Focht, Meisser, Morgan, Pahor, Pennix, 2002). The Swedish Obese
Subjects study found no beneficial effects for their non-surgical weight loss intervention on the
impact of pain on work environment (Peltonen, Lindroos, Torgeson, 2003). However, in the
SOS study obese persons had more “work-restricting pain” than the general population
(Peltonen, et al., 2003), and interference by pain in other domains was not assessed. Further, the
SOS study observed that only the surgical obesity treatment reduced the long-term risk of
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developing work-restricting musculoskeletal pain, and also increased the likelihood of
recovering from such pain (Peltonen, et al., 2003). As the present study is using an intensive
medical intervention as its active treatment component, it appears particularly important to
understand the potential contributing effects of pain on the efficacy of this type of intervention.
A valuable contribution of this study is to understand how self-reported pain at the outset of
treatment may affect success in a medical intervention for morbid obesity.
Aside from the sole presence of pain, another factor that may disrupt the efficacy of
medical weight loss interventions is pain beliefs. As stated above, there are currently no
published studies that investigate how pain beliefs, specifically catastrophizing, may impact
individuals’ responsiveness to weight loss interventions. The present study relied heavily on selfreport measures of participants’ pain, thus it was important to control for the potential effects of
cognition on individual’s experience of pain within the study.
In the Louisiana Obese Subjects Study (LOSS), patients randomized to the intensive
medical intervention (consisting of group therapy, medication, diet, and toolbox treatments) were
compared with usual care participants, allowing an empirical examination of these questions. If
the presence of pain or pain catastrophizing significantly reduced the efficacy of non-surgical
interventions, this would lend compelling support for the incorporation of empirically supported
pain treatments (such as cognitive behavioral therapy) in obesity rehabilitation programs. Thus,
the following aims were proposed for examination:
Primary Aim
1. The primary aim of this study was to assess how pain may affect the outcome of the intensive
medical weight loss treatment. It was hypothesized that the presence of pain, pain severity,
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and pain interference would predict less weight loss overall and poorer response to treatment
one year after receiving the intensive medical treatment.
Secondary Aims
2. A secondary aim of this study was to determine how pain beliefs, specifically pain
catastrophizing, may affect treatment outcome. Participants who reported higher levels of
pain catastrophizing were expected to have the poorest response to the intensive medical
intervention.
3. A basic aim of this study was to evaluate and record the pain that these morbidly obese
individuals were experiencing. Pain was hypothesized to be reported within a significant
percentage of this sample. Following the direction of previous research, demographic
variables and self-reported depression symptomatology were controlled.
4. Another aim of this study was to assess the functional interference of self-reported pain in
participants’ daily functioning and quality of life. It was hypothesized that when compared to
participants not experiencing pain, greater levels of disability would be reported by
participants experiencing pain on a measure of health-related quality of life (SF-36).
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METHOD
Participants
All participants for the current project were recruited as part of a study entitled
“Louisiana Obese Subjects Study (LOSS): Pragmatic Clinical Evaluation of Treatments for
Severe Obesity for State Group Benefits Members in Louisiana,” funded by the Louisiana Office
of Group Benefits (OGB). Participants of the current study included 390 morbidly obese
individuals who qualified for state medical insurance benefits through OGB at the time of
screening and randomization. Participants were initially seen at one of eight clinical sites in
Louisiana. Males and non-pregnant females aged 20-60 years, with BMI > 40 kg/m2 but < 60
kg/m2 were recruited for the parent study. Participants were excluded for factors that might limit
adherence to interventions or affect the conduct of the trial, including but not limited to: recent
hospitalization for psychiatric illness or substance abuse, history of eating disorder, current
pregnancy or nursing, prior bariatric surgery, or bowel resection. Diagnosis or current treatment
for several medical disorders (e.g., HIV, Hepatitis C, tuberculosis, severe congestive heart
failure, cancer) or mental illness (e.g., psychotic or bipolar disorders or current major depressive
episode) that would make an individual unsuitable for an intensive medical weight loss
intervention were also basis for exclusion. To maximize high participant retention across study
sites, the following methods were employed: use of incentive programs, supplemental materials,
personal contact by study staff, mailed reminders, motivational interviewing, participant goal
setting, and problem solving/overcoming barriers. Incentive programs included free medical
screening and store and gas gift cards for attendance at follow-up study visits.
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Measures
Medical Outcomes Survey (SF-36). The Medical Outcomes Study Short Form Health
Survey (SF-36; Ware, Snow, Kosinski, Gandek, 1993) is a self-administered questionnaire that
assesses eight domains of functioning: physical functioning, role limitations due to physical
problems, vitality, bodily pain, social functioning, role limitations due to emotional problems,
mental health, and general health perception. The eight scales have also been shown to form two
distinct higher-order clusters due to the physical and mental health variance they have in
common. Factor analytic studies have confirmed physical and mental health factors that account
for 80-85% of the reliable variance in the eight scales (Ware, et al., 1993). Three scales (physical
functioning, role limitations due to physical problems, and bodily pain) correlate the most highly
with the physical component and contribute to the scoring of the Physical Component Summary
measure. The mental health, role limitations due to emotional problems, and social functioning
scales contribute to the scoring of the Mental Component Summary measure (Ware, Kosinski,
Keller, 1994). The other two scales have noteworthy correlations with both component measures.
The SF-36 possesses sound psychometric properties (Stewart & Hays, 1992) and has been used
in a variety of health care contexts to assess health-related quality of life across the multiple
domains described above (Ware, 2000; Ware & Kosinski, 2001).
Due to the extensive use of the SF-36, research has demonstrated that the scales on the
Physical Component Summary measure are most responsive to treatments that change physical
morbidity (Ware, 2000; Ware & Kosinski, 2001), including studies of weight loss treatments
(Kolotkin, et al., 2009). The present study applied the principles of other weight loss treatment
studies and limited the factors of health-related quality of life explored here (i.e., severe
comorbid illness, depression). Furthermore, the present study aimed to examine those domains
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most relevant to pain-related quality of life, specifically: physical functioning, role limitations
due to physical problems, and bodily pain (Ware & Kosinski, 2001). Therefore, the Physical
Component Summary measure provided the best estimate of functional health and disability for
the present study.
Brief Pain Inventory (BPI). The BPI, in the short form (Cleeland, 1989; Keller, Bann,
Dodd, Schien, Mendoza, Cleeland, 2004), is a nine-item self-report measure. The BPI is a
condition-specific quality of life measure that provides detailed information about the impact of
pain on daily functioning in several domains, including occupational, interpersonal, and
emotional realms. The BPI was developed to provide a quick and efficient means of measuring
pain presence, location, intensity, and the extent to which pain interferes in the lives of pain
sufferers (Keller et al., 2004). Using a 1-10 scale, respondents rate their worst, least, average, and
current pain intensity, and also rate the degree to which pain interferes with seven domains of
functioning (general activity, mood, walking ability, normal work, relations with others, sleep
and enjoyment of life). The BPI can be computed to generate two subscale scores: Pain Severity
and Pain Interference (Cleeland, 1989; Keller, et al., 2004). The BPI has been used extensively in
cancer pain populations, and has been translated into many different languages and is used
throughout the world. The BPI was also validated in two chronic, nonmalignant pain populations
(Keller et al., 2004; Tan, Jensen, Thornby, Shanti, 2004). Internal consistency is acceptable, with
an  coefficient of .85 for the intensity scale and .88 for the interference scale. The BPI has also
been noted to have good convergent validity with other general measures of health related
quality of life, such as the bodily pain and physical role functioning scales of the SF-36 (Keller,
et al., 2004). Thus, the BPI is a reliable, valid, and sensitive to change instrument for assessing
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pain intensity and interference in patients with nonmalignant pain and for the general population
who may have chronic intractable pain.
Pain Catastrophizing Scale (PCS). The PCS is a thirteen-item self-report instrument
that describes different thoughts and feelings individuals may experience when they are in pain.
The PCS asks participants about the extent to which they ruminate, magnify, and experience
helplessness with regard to their pain symptoms. Participants reflect on each of the questions
and respond on five-point scales with the endpoints of (0) “not at all” to (4) “all of the time.”
Examples of statements that participants are asked to rate are, “My pain is awful and I feel it
overwhelms me” and “When I am in pain I feel I can’t go on.” The PCS yields three subscale
scores of rumination, magnification, and helplessness, as well as a total score. The PCS has been
shown to have adequate to excellent internal consistency with  coefficients of: rumination =
0.87, magnification = 0.66, helplessness = 0.78 and Total PCS = 0.87 (Sullivan, Bishop, & Pivik,
1995). The PCS has also been used extensively in both chronic and experimental pain
populations (Osman, Barrios, Kopper, Hauptmann, Jones, O’Neil, 1997), and has been translated
into several languages (Turner & Aaron, 2001).
Center for Epidemiological Study and Depression Scale (CES-D). Developed by
Radloff (1977), the CES-D is a 20-item self-report measure of depressive symptomatology.
Respondents rate the frequency of occurrence in the past week of each symptom on a four-point
scale ranging from “rarely or none of the time (less than 1 day)” to “most of the time or all of the
time (5-7 days).” On the CES-D, scores range from 0 to 60, with higher scores indicating more
symptoms of depression. CES-D scores of 16 to 26 indicate mild depression and scores of 27 or
greater may indicate major depression (Martens, et al., 2006; Radloff, 1977). A score of “16” or
greater indicates increased risk for the diagnosis of depression (Radloff, 1977). The CES-D has

22

been extensively used in primary care and community based studies. In studies of depression
prevalence among primary care and arthritic pain patients, a score of “19” has been suggested as
a more optimal sensitivity point to avoid false-positive identification of depression (Martens,
Parker, Smarr, Hewett, Ge, Slaughter, Walker, 2006). However, in the present study, a score of
“16” required that a clinical psychologist review the participant’s medical and psychiatric history
to give approval for study entry, as a more stringent control of the study’s exclusion criteria.
Body Weight. The formula for calculation of BMI = weight [kg] divided by height [m2]
(WHO, 2011). All weight information provided in this study is reported in kilograms. Height and
weight were measured via standardized protocol using annually calibrated measuring devices
and scales at each clinical site.
Procedure
Overall LOSS Design. The primary aim of the LOSS study was to observe the effect of
an intensive medical management program versus usual care for class III obesity (BMI > 40kg/
m2) on weight loss, total medical costs and on measures of health risks associated with weight
loss. LOSS was structured as a pragmatic clinical trial (PCT; Tunis, Stryer, & Clancy, 2003). As
such, the interventions chosen were designed to mimic medical practice patterns of care. LOSS
was characterized by three major study periods: screening and randomization, active weight loss
in years 1-3, and observation in years 4-5 (see Figure 1). All individuals with medical insurance
supplied by OGB were invited to participate in informational sessions. Screening and
randomization was conducted across two visits. Randomization employed stratification for sex,
BMI, and age, and was designed to yield comparable samples with regard to baseline prognostic
factors. Screening, randomization, and the observation period in years 4-5 were structured
similarly for all participants, regardless of group assignment.
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597 Attended screening
visits at eight clinical sites (Alexandria, Baton
Rouge, Hammond, Lafayette, Lake Charles,
Monroe, New Orleans, and Shreveport)

132 Excluded;
Did not meet entry criteria

465 Randomized

75 Excluded;
3 Had weight loss surgery
72 New Orleans site post-Katrina
and Monroe site

200 Intensive Medical Intervention

190 Usual Care

Figure 1. Louisiana Obese Subjects Study Recruitment and Retention
Participants agreed to randomization to one of two treatment conditions in years 1-3 of
the study: usual care condition or intensive medical approaches. The usual care group received
initial instruction in the use of the Mayo Clinic Weight Management website but otherwise
received usual care from their primary care provider. For study purposes, usual care participants
were also monitored annually with a health screening examination at the clinical site. The active
weight loss period for the intensive medical management condition was structured into three
phases. Phase 1 had a duration of approximately three months, during which participants
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followed a prescribed very low calorie diet (VLCD). Following the initial VLCD phase, Phase 2
of the intensive medical intervention utilized a highly structured diet, and introduced weight loss
medication and regular behavioral therapy schedule that spanned four months. Phase 3 began in
month 8 and lasted to month 36. Phase 3 began the maintenance program which was instituted to
maintain weight loss over the long term.
Clinical Sites. LOSS was conducted at seven of the eight original clinical sites in the
state of Louisiana (Baton Rouge, Lafayette, Lake Charles, Alexandria, Monroe, Hammond, and
Shreveport). As the LOSS study began recruitment and screening in summer 2005, the New
Orleans site was directly impacted by Hurricane Katrina. The remaining clinical sites absorbed
most of the New Orleans-based participant base for continued study involvement. However, the
participants from the New Orleans site were excluded from study analysis due to catastrophic
exposure and life change that could not be accounted for in the context of the present study.
Participants from the Monroe site were also excluded due to problems with adherence to study
protocol by the clinical site staff (e.g., failure to schedule study visits). Lastly, three participants
were excluded because they underwent weight loss surgery during the study period on their own,
independent from the LOSS study and OGB (see Figure 1).
Current Study. Treatment outcome will be operationalized as percentage change of
initial body weight (IBW), per IOM standards for clinically significant weight loss in nonoperative treatment studies. Thus, the primary endpoint of the current study was the same as that
of the original LOSS study. The current study aimed to capture the impact of self-reported pain,
pain intensity, pain severity, and pain catastrophizing on treatment outcome. Measurement of the
above constructs occurred at baseline/ randomization and month 12 of the LOSS study for all
participants.
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Power Analyses
Power analyses were conducted for the parent study, and given that both the parent and
the current studies use the same primary endpoint, these calculations are applicable here (Ryan,
et al., 2010). Power analyses were conducted under the usual assumptions of ANOVA, and with
a type 1 error rate of 5%, or alpha set at 0.05, 2-tailed for all analyses. For the original LOSS
study, two hypotheses were addressed: 1) that weight loss for the intervention group exceeded
20% of initial body weight, and 2) that weight loss for the intervention group exceeded that of
the usual care group. As such, power calculations were carried out for weight change from
baseline in kilograms to the end of the intervention period and to the end of the study. The
estimate of standard deviation for weight loss employed in the power calculations was taken to
be 16 kilograms. This value, an estimate provided by the authors of the Swedish Obese Subjects
study (Sjöström, 2000; Sjöström, Lissner, Wedel, Sjöström, 1999), was chosen because it
produced a highly conservative approach to power analyses. With sample size of 240, a
difference in weight loss (Intensive Medical Intervention - Usual Care) of as little as 3.46 kg
would be required for 80% power for the test of treatment effect. Allowing for a 25% dropout
rate, the parent LOSS study calculated that sample size of 180 required a minimum difference
between groups (Intensive Medical Intervention - Usual Care) of 4.2 kg for 80% power.
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RESULTS
Sample Characteristics and Descriptive Analyses
Baseline characteristics of the 390 randomized participants are depicted in Table 1. The
mean age of the population was 47 years, and they were predominantly white (75%) and female
(83%). At randomization, the coordinating center randomly assigned participants to intensive
medical intervention (IMI) or usual care (UC) by applying minimization allocation with
stratification by age, sex, and BMI to achieve allocations that were comparable with specified
baseline prognostic factors. For stratification, age and BMI were dichotomized as follows: age
(in years) 20 or older but younger than 40, or 40 or older, up to and including 60; and BMI of 40
or higher but less than 45, or 45 and higher, up to and including 60. As expected, there were no
group differences in age, sex, BMI, and race.
Table 1
Baseline Characteristics of Participants

Age, mean (SE), in years
Male, total number (%)
White
Black
Female, total number (%)
White
Black
Hispanic
Weight, median (IQR), kg
BMI, median (IQR)
Male
Female
IQR = interquartile range

IMI (n = 200)
47.2 (0.6)
33 (16.5)
29 (14.5)
4 (2.0)
167 (83.5)
120 (60.0)
46 (23.0)
1 (0.5)
126.2 (23.2)
45.6 (7.9)
44.9 (7.2)
45.7 (8.0)

UC (n = 190)
47.1 (0.6)
31 (16.3)
26 (13.7)
5 (2.2)
159 (83.7)
121 (63.7)
38 (20.0)
0 (0.0)
128.4 (28.6)
46.6 (8.5)
46.4 (9.6)
46.8 (8.4)

Common comorbid medical conditions to obesity reported at screening are reported in
Table 2. Occurrence of congestive heart failure and coronary artery disease is relatively low, as
severe congestive heart failure and the occurrence of a cardiovascular event in the past year prior
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to screening were exclusion criteria for LOSS. Hypertension (84.6%) was the comorbid
condition reported by the most participants. Pre-existing pain conditions (e.g., fibromyalgia,
neuropathy, osteoarthritis) were not recorded consistently at the screening visit to provide
estimates for this sample. A basic aim of the study was to evaluate and record the pain reported
by participants. At the time of randomization, scores on the BPI indicated that 36.7% of the
sample (N=378) reported the presence of “pain today.” This was a direct response to the
question of whether the participant was experiencing pain that was beyond ‘everyday’ pain on
that day. By gender, 39% of males and 37% of females reported pain today (see Table 2). BPI
at randomization was not available for twelve participants. An independent sample t-test was
conducted to compare pain today and completer status. There was no a significant group
difference (completers versus non-completers) in self-reported presence of pain (t (376) = -.55,
p=.58).
Table 2
Health-Related Sample Characteristics

Congestive Heart Failure
Coronary Artery Disease
Diabetes Mellitus
Insulin use
Hypertension
Hyperlipidemia
Pain Today
Males
Females

N
16
30
80
21
330
125
143
25
120

%
4.1
7.7
20.5
5.4
84.6
32.1
36.7
39
36.8

Due to the potential adverse impact on compliance, the current study made extra efforts
to control for depression (Wright, et al., 2010), as the case of any randomized participant with
CES-D scores at 16 or greater was reviewed by a clinical psychologist. Recall that on the CES-

28

D, a score of 16 or greater indicates an increased risk for the diagnosis of depression, although
minimal impact (Martens, et al., 2006; Radloff, 1977). Of the 390 participants who completed
the CES-D at randomization, only eleven participants (2.8%) had scores greater than 16, and of
these, three (0.7%) were greater than 27. Scores of 27 or greater may indicate major depression
(Martens, et al., 2006). The highest CES-D score reported was 32. A review of study records
indicated that protocol was followed for these participants, whose charts were reviewed.
Correlations of Predictor and Criterion Variables
Preliminary analyses were conducted to determine if there were intercorrelations amongst
the set of predictors (i.e., the Physical Component Summary subscale of the SF-36, BPI pain
today, BPI Pain Severity, BPI Pain Interference, and PCS) and depression (CES-D). High
correlations (r > 0.7) amongst the predictors could indicate common underlying factor(s).
Pearson r correlations are displayed in Table 3. Many scales were moderately correlated with
each other. As expected, both Pain Severity and Pain Interference from the BPI were moderately
correlated with the SF-36 Physical Components Summary. The BPI has been noted to have good
convergent validity with other general measures of health-related quality of life, such the SF-36
(Keller, et al., 2004). Pain Interference and Severity were highly correlated with one another (r =
0.78, p < .001).
Intercorrelations of the predictor and criterion variables with age, sex, BMI, and
depression were also computed prior to regression calculations, as displayed in Table 4. A
modest negative correlation was found between age and pain today. Depression was significantly
correlated with Pain Severity, Pain Interference, and Pain Catastrophizing. Lastly, age, BMI, and
depression were negatively all correlated to the Physical Components Summary of the SF-36.
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Table 3
Correlations of Predictor and Criterion Variables

Percent Change of
Initial Body Weight

Physical
Components
Summary
-.13

Physical Components
Summary

Pain
Today

Pain
Severity

Pain
Interference

Pain
Catastrophizing

-.14*

.18*

.18*

.04

.33**

-.52**

-.65**

-.34**

-.40**

-.33**

-.15**

.78**

.38**

Pain Today
Pain Severity
Pain Interference

.48**

** Correlation is significant at the 0.01 level (2-tailed).
* Correlation is significant at the 0.05 level (2-tailed).
Table 4
Correlations of Predictor and Criterion Variables with Demographic Indices, BMI at
Randomization, and Depression

Pain Today

Age
-.12*

Race
.06

Sex
.03

BMI
-.10

Depression
.04

Pain Severity

.01

.08

.02

.03

.26**

Pain Interference

.05

.01

.03

.11

.32**

Pain Catastrophizing
Total

.07

.05

.05

.13

.42**

Percent Change of
Initial Body Weight

-.02

.08

.07

-.02

.08

Physical Components
Summary

-.24**

.05

-.11

-.28**

-.20**

** Correlation is significant at the 0.01 level (2-tailed).
* Correlation is significant at the 0.05 level (2-tailed).
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Missing Data
Missing data were deleted listwise such that these regression analyses represent a
completers analysis of all participants for whom weights were available at Year 1. A rigorous
missing data statistical plan was proposed, with different mechanisms that led to missing data
analyzed. Sensitivity of the different statistical methods (completers analysis, baseline
observation carried forward analysis, last observation carried forward) were verified to be robust
in the original LOSS dataset (Ryan, et al., 2010). Furthermore, the completers analysis was used
without significantly reducing variance or power, which is a common concern for partially
missing data (Tabachnick & Fidell, 2007). There were no differences in age, sex, BMI, or race
observed in those individuals who completed the Year 1 measurement (N = 208; 53% of baseline
sample) and those who did not.
Primary Aim
The primary aim of this study was to assess the extent to which self-reported pain at the
outset of treatment may affect the success of the intensive medical weight loss treatment. The
literature does not indicate an empirical basis for which the presence of pain, pain severity, or
pain interference should predict overall weight loss. As reported in the main outcome results of
the parent LOSS study, treatment condition was associated with significant differences at Year 1
(Ryan, et al., 2010). Specifically, at Year 1 among the 60% of attending IMI participants, the
mean weight loss was 13.9%, yet only 0.9% for the 50% of attending UC participants. To control
for the main effect of treatment condition, group assignment was entered into the regression
equation first. Since the different components of the BPI were highly correlated, they were
entered in a stepwise fashion in order to avoid problems of multi-collinearity in the regression
equations. Hierarchical regression analyses were performed to further analyze the strength of the
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associations between percentage change of IBW and self-reported pain. After control of
treatment condition, the following variables from the BPI were entered into the regression
equation: pain today, pain severity, and pain interference.
Results of the regression for the prediction of percent change of IBW are summarized in
Table 5. As consistent with previous studies, the independent impact of depression was
controlled for and entered into Step 1 of the analysis. It did not contribute significant variance
into the model. As expected, R for regression was significantly different from zero for treatment
condition [F(2,206) = 27.71, p < .001] in Step 2. Inspection of R2 indicates that treatment
condition predicted approximately 24% of the variability within treatment outcome (R² = .24,
adjusted R² = .24). In Step 3, the pain indices were allowed to compete for entry in the next step
of the analysis. Pain severity was the only variable to meet minimum criteria for entry [F(3,205)
= 20.50, p < .001], such that increasing levels of pain severity were associated with poorer
treatment outcome. The final model predicted 29% of the variance in treatment outcome, with
pain severity accounting for an incremental 5% of the variance in percent change of IBW.
Table 5
Hierarchical Regression Analyses Predicting Percent Change of Initial Body Weight

Step 1
Depression
Step 2
Treatment Condition
Step 3
Pain Today
Pain Severity
Pain Interference

R2
.01

ß

p

.08

.29

-.49**

.00

.06
.15**
.05

.37
.01
.58

.24**
.29**
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Secondary Aims
A secondary aim of this study was to determine how pain beliefs, specifically pain
catastrophizing, may affect treatment outcome. Participants who reported higher levels of pain
catastrophizing were expected to have the poorest response to the intensive medical intervention.
The authors of the Pain Catastrophizing Scale define a cut-off score for clinically relevant levels
of catastrophizing as a total PCS score of 30 (Sullivan, 2009). This score corresponds to the 75th
percentile of the distribution of PCS scores in clinic samples of chronic pain patients.
Unfortunately, the PCS was only administered to IMI participants at their randomization visit, so
limited data are available for this measure (N = 193). Among this group, levels of pain
catastrophizing were very low, with only five participants (2.5%) reporting PCS Total score >
30. Ninety-three percent of the group who completed the PCS had scores lower than 20 (50%ile).
Thus, no further analysis of pain beliefs was available.
Another aim of this study was to assess the functional interference of self-reported pain in
participants’ quality of life. It was hypothesized that when compared to participants not
experiencing pain, greater levels of disability would be reported by participants experiencing
pain on a measure of health-related quality of life (SF-36). Self-reported pain for this research
question was operationalized using scores on the BPI at randomization to indicate if patients
reported pain on that day. BPI Pain Severity and Pain Interference scores were not used, as the
correlations with the dependent variable (i.e, Physical Component Summary score of the SF-36
at randomization) were too high and multi-collinearity was again a concern. Simultaneous
regression was used, with the sample subset of completers analyzed as in the regression for the
primary research aim. Age, BMI, and depression were controlled for in this model, as these
variables were reported above to have significant correlations with the dependent variable. R for
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regression was significantly different from zero for the presence of pain [F(4,204) = 14.61, p <
.001]. Inspection of R2 indicates that the self-reported presence of pain predicted approximately
11% of the variability within health-related quality of life (R² = .11, adjusted R² = .11). The
effect size is large by Cohen’s d standards (r = .51).
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DISCUSSION
The present study was the first to assess the presence of pain, pain-related disability, and
pain beliefs in the context of a pragmatic clinical trial to mimic medical practice patterns of care
for the treatment of obesity. Taken as a whole, results indicate that pain and pain severity are
significantly associated with weight loss treatment outcome after one year of intervention.
Further, the presence of pain is independently associated with decrements in health-related
quality of life, after controlling for age, BMI, and depression. The primary aim of the current
study was to assess the extent to which self-reported pain would affect the success of the
intensive medical weight loss treatment. Pain severity at the outset of treatment was significantly
associated with greater percentage change in initial body weight, even after controlling for the
impact of depression and treatment condition. The direction of the relationship was such that
increasing levels of pain severity at the outset of treatment was significantly associated with
poorer treatment outcome in both groups. The same relationship was not observed for pain
interference or the mere presence of self-reported pain. The findings of the present study provide
preliminary evidence that pain severity is an important indicator of treatment outcomes for
extremely obese individuals trying to lose weight by nonsurgical methods.
In the present sample, pain was reported by over one-third of participants. This was
operationalized as self-reported pain that was beyond ‘everyday’ pain on a single day.
Participants provided a binary response. This assessment method was similar to that of The
Gallup Organization (Stone & Broderick, 2012). Their survey of pain that occurred yesterday as
a “yes” or “no” response was applied to reduce recall biases associated with the longer reporting
periods (up to three months) often used in pain assessment (Wright, et al., 2010). However, this
is also a consideration for the interpretation of these results, as there is a trade-off in minimizing
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recall bias with the depth of measurement beyond one day. Pain reported in this manner may not
capture the typical pain experience for an individual. The frequency of pain in this sample was
also lower than expected. Previous research has reported frequencies of comorbid pain ranging
from 56 to 68% in samples of weight treatment seeking, obese adults (Fontaine, et al, 2000;
Fontaine & Barofsky, 2001; Peltonen, Lindroos, Torgeson, 2003). Although among nontreatment-seeking, but similarly obese counterparts, pain has been observed in approximately
one-third of participants (Fontaine, et al., 2000; Wright, et al., 2010). One reason for this
relatively low finding may be the highly controlled sample. Specifically, prior to randomization,
careful attention was made to control for demographic variables and depression, known factors
to be associated with higher levels of self-reported pain. This may be a more accurate and
conservative frequency estimate of pain, as known correlates have not only been statistically
controlled, but excluded from this sample.
The present sample was also highly controlled for BMI, in that the study focused on
morbid, class III obesity. The estimates provided above are for treatment-seeking adults from a
range of BMI classes. The present study would not suggest that morbidly obese individuals have
less pain than with lesser degrees of excess weight. Instead, for individuals at such high BMI,
duration and chronicity of pain and comorbid health conditions may provide contextual evidence
for this reporting. Morbid obesity is typically associated with serious health complications and
conditions, many of which are associated with and contribute to pain. Morbid obesity is also not
a quickly resolving condition, thus individuals are experiencing both excess weight and related
consequences for a number of years. Sullivan and colleagues (2002) reported that the number of
years since the onset of pain (i.e., pain chronicity) may significantly affect individuals’ reporting
of pain, as well as moderate the relationship between cognitive appraisal of pain and pain-related
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disability. The longer an individual experiences pain conditions, the lower their expectancies for
symptom resolution and treatment outcome. Chronic pain conditions are often characterized by
repeated treatment failures and exhaustion of treatment outcomes, and the appraisal of ‘common’
pain changes (Sullivan, et al., 2002). The participants in this sample were specifically asked
about pain that was in excess of “everyday” pain, which may have underestimated the degree of
pain they were experiencing.
The contribution of pain beliefs, specifically catastrophizing, to treatment outcome was
not understood in the present study. Participants who reported higher levels of pain
catastrophizing were expected to have the poorest response to the intensive medical intervention.
However, problems with questionnaire administration led to failure of the construct to be
assessed in the entire sample. When analyzed for score ranges, levels of total pain
catastrophizing were very low, so as to preclude further analysis of the impact of pain beliefs.
This may again be a function of the control for depressive symptomatology in the sample. The
construct of catastrophizing was used by Beck (1976) to describe a ‘cognitive distortion’ that
could contribute to the development or exacerbation of depressive and anxious symptoms.
Literature suggests that the essential features of catastrophizing in depression and anxiety may be
similar to those of catastrophizing as discussed in the pain literature (Turner & Aaron, 2001).
The lack of catastrophizing beliefs about pain in this sample likely suggests this hypothesis is
true. Furthermore, as suggested by Sullivan and colleagues (2002), there is also evidence that the
psychological correlates of pain-related disability change over time. They reported that the stage
of pain chronicity also moderated the relationship between PCS subscales and pain-related
disability, such that helplessness (but not magnification or rumination) was seen more in chronic
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pain patients. With a more diverse sample of weight loss treatment seeking adults, this
relationship could be explored further.
The presence of pain in the current sample was independently associated with decrements
in health-related quality of life, after controlling for age, BMI, and depression. With large effect
size, this finding is especially robust, considering that only one-third of the sample reported pain
today on the BPI, below the prevalence suggested in the literature. Research has hypothesized
that the comorbidity of physical pain and obesity may act in a reciprocal fashion to increase
physical disability, and this further indicates that pain may independently decrease quality of life
and increase disability for morbidly obese patients. This finding provides evidence for the
importance of assessing pain in obese patients, particularly those seeking treatment for weight
loss. For morbidly obese adults with multiple chronic health conditions, the assessment of both
pain presence and comorbid pain-related conditions is important so that researchers may control
for the contribution of comorbidities to both pain and quality of life.
One proposed mechanism of the reciprocal obesity-pain relationship on health-related
quality of life is the negative impact of sedentary behavior on both conditions. That is, obesity
may increase the risk for pain-related illness through increased load on the body. Yet, the
sedentary lifestyle of overweight individuals may contribute to increased risk of pain conditions
(Leboeuf-Yde, et al., 1999; Shiri, et al., 2010). While exercise is an important part of
multidisciplinary treatment of both chronic pain and obesity, there is reduced exercise capacity in
obese women (Hulens, Vansant, Lysens, Claessens, Muls, 2001), due to complaints of
musculoskeletal pain. Therefore, alternative exercise programs in conjunction with weight
reduction may be necessary for obese chronic pain patients.
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Limitations and Future Directions
Interpretation of these data is limited by several factors. First, although there were no
significant group differences found between individuals who did and did not complete the year 1
weight measurement, the retention rate was lower than anticipated in the parent study’s power
calculations. The issue of poor retention in weight loss studies is well known, and it takes special
efforts to produce excellent retention rates such as in the Diabetes Prevention Program and the
Look AHEAD trials (Pi-Sunyer, et al., 2007). Participant retention in both 1- and 2- year weight
loss studies, especially medication-based programs, is approximately 50%, similar to that of the
current study (Hauptman, et al., 2000; Pi-Sunyer, et al., 2007; Sjöström, et al.,1999). Ryan and
colleagues (2010) suggested that it may be expected for primary care physicians to observe that
only half of their patients seeking weight loss intervention may remain in the program. However,
for those who continue treatment, weight loss is achieved. Although the retention in the current
study may mimic real-world weight loss behavior, it was less than desired (Simmons-Morton,
Obarzanek, & Cutler, 2006).
The generalizability of these findings is also affected by the limitations of the study
design, particularly the use of self-report measures, the small homogeneous sample, and lack of
comparison measures between treatment conditions at more than two time points. Pain, pain
catastrophizing, and pain-related disability were measured with self-report questionnaires.
Assessment by this method must be cautious given that self-reporting can be influenced by
numerous factors including cognitive abilities, mood, sleep disturbance, and medication usage
(Peter & Watt-Watson, 2002). In the current study, attempts were made to control for depressive
symptoms, which were found not to contribute to the treatment outcome. Self-report methods are
inherent to pain assessment (Greve, Bianchini, Ord, 2012); however, more objective observance
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of pain-related behavior would add value to the understanding of pain in this population.
Specifically, future studies should make provisions to more closely monitor medication usage
over the course of the study. Thus, the use of self-report exclusively for these behaviors requires
that the current findings be considered with caution.
The sample was homogeneous as it consisted only of morbidly obese adults seeking
treatment for weight loss, from a recruitment pool of state employees and dependents who
qualified for state medical insurance benefits. The sample was predominantly female and white.
Given the restriction by participant BMI, generalizability of the current results are limited in that
they cannot be applied across the larger spectrum of overweight and obesity. Extreme or morbid
obesity is typically associated with more serious health complications than lesser degrees of
excess weight. Although this sample has a high proportion of comorbid chronic illnesses, it was
not accessed to which illnesses pain may be attributed. Recruitment was also limited to
individuals who are state employees or their dependents. Results may have differed if
participants from a broader cross-section of the state population were recruited. Yet, the present
study had the distinct advantage of representation from multiple areas of the state.
The research generally accepts weight losses of 5% or more as associated with improved
health outcomes (Sjöström, et al.,1999). The present study was not designed to test the effect of
sustained modest weight loss in extreme obesity, particularly on its impact towards pain.
Recommendations for some pain conditions (i.e., osteoarthritis) include weight loss in pain
treatment. Even modest increases in BMI are related to the development and progression of pain
disorders (Holmberg, Thelin, & Thelin, 2005); reciprocally, decreases in weight may impact
pain. Thus, it would be expected that weight loss over the course of the medical intervention
would impact participants’ reported pain positively. Future studies of larger weight-loss-seeking
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samples should focus assessment of pain, related pain conditions, and pain medication usage to
understand better the impact of incremental weight loss on pain outcomes. Furthermore, the
current study did not evaluate a causal relationship between pain and obesity. There was no
identification of relationship between development of obesity before or after occurrence of pain
symptoms to suggest if obesity occurred before or after, possibly as a consequence, of pain
symptoms. If a causal relationship can be identified, then studies could be developed to evaluate
the benefits of weight reduction as a treatment for pain, with measurements of depression,
disability, and quality of life as outcome measures.
Conclusions
Despite these limitations, the findings of the present study provide preliminary evidence
that pain severity is an important indicator of treatment outcomes for extremely obese
individuals trying to lose weight by non-surgical methods. There is still much to learn about the
co-occurrence of pain and obesity. Continued research is necessary, applying rigorous scientific
methodology to investigate the causal sequence and interaction of these variables, and to expand
understanding of the reciprocal relationship. Further examination of subsequent effects on
health-related outcomes and medication usage would be beneficial. Explanatory models need to
be developed and treatments tested to most effectively target this comorbidity and meet the needs
of individuals struggling with both excess weight and pain.
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